189 related articles for article (PubMed ID: 27032748)
1. The G-quadruplex-forming aptamer AS1411 potently inhibits HIV-1 attachment to the host cell.
Perrone R; Butovskaya E; Lago S; Garzino-Demo A; Pannecouque C; Palù G; Richter SN
Int J Antimicrob Agents; 2016 Apr; 47(4):311-6. PubMed ID: 27032748
[TBL] [Abstract][Full Text] [Related]
2. Anticancer molecule AS1411 exhibits low nanomolar antiviral activity against HIV-1.
Métifiot M; Amrane S; Mergny JL; Andreola ML
Biochimie; 2015 Nov; 118():173-5. PubMed ID: 26363100
[TBL] [Abstract][Full Text] [Related]
3. G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: Uses and mechanisms.
Bates PJ; Reyes-Reyes EM; Malik MT; Murphy EM; O'Toole MG; Trent JO
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1414-1428. PubMed ID: 28007579
[TBL] [Abstract][Full Text] [Related]
4. Aptamer-based Targeted Delivery of a G-quadruplex Ligand in Cervical Cancer Cells.
Carvalho J; Paiva A; Cabral Campello MP; Paulo A; Mergny JL; Salgado GF; Queiroz JA; Cruz C
Sci Rep; 2019 May; 9(1):7945. PubMed ID: 31138870
[TBL] [Abstract][Full Text] [Related]
5. A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism.
Reyes-Reyes EM; Teng Y; Bates PJ
Cancer Res; 2010 Nov; 70(21):8617-29. PubMed ID: 20861190
[TBL] [Abstract][Full Text] [Related]
6. Aptamer-based approaches to detect nucleolin in prostate cancer.
Miranda A; Santos T; Carvalho J; Alexandre D; Jardim A; Caneira CF; Vaz V; Pereira B; Godinho R; Brito D; Chu V; Conde JP; Cruz C
Talanta; 2021 May; 226():122037. PubMed ID: 33676639
[TBL] [Abstract][Full Text] [Related]
7. AS1411-functionalized delivery nanosystems for targeted cancer therapy.
Kozani PS; Kozani PS; Malik MT
Explor Med; 2021; 2():146-166. PubMed ID: 34723284
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation.
Reyes-Reyes EM; Šalipur FR; Shams M; Forsthoefel MK; Bates PJ
Mol Oncol; 2015 Aug; 9(7):1392-405. PubMed ID: 25911416
[TBL] [Abstract][Full Text] [Related]
9. Locking up the AS1411 Aptamer with a Flanking Duplex: Towards an Improved Nucleolin-Targeting.
Miranda A; Santos T; Largy E; Cruz C
Pharmaceuticals (Basel); 2021 Feb; 14(2):. PubMed ID: 33557379
[TBL] [Abstract][Full Text] [Related]
10. Azasugar-containing phosphorothioate oligonucleotide (AZPSON) DBM-2198 inhibits human immunodeficiency virus type 1 (HIV-1) replication by blocking HIV-1 gp120 without affecting the V3 region.
Lee J; Byeon SE; Jung JY; Kang MH; Park YJ; Jung KE; Bae YS
Mol Cells; 2015; 38(2):122-9. PubMed ID: 25623024
[TBL] [Abstract][Full Text] [Related]
11. Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells.
Soundararajan S; Wang L; Sridharan V; Chen W; Courtenay-Luck N; Jones D; Spicer EK; Fernandes DJ
Mol Pharmacol; 2009 Nov; 76(5):984-91. PubMed ID: 19657047
[TBL] [Abstract][Full Text] [Related]
12. Corneal neovascularization is inhibited with nucleolin-binding aptamer, AS1411.
Vivanco-Rojas O; García-Bermúdez MY; Iturriaga-Goyon E; Rebollo W; Buentello-Volante B; Magaña-Guerrero FS; Bates P; Pérez-Torres A; Garfias Y
Exp Eye Res; 2020 Apr; 193():107977. PubMed ID: 32081668
[TBL] [Abstract][Full Text] [Related]
13. AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin.
Cheng Y; Zhao G; Zhang S; Nigim F; Zhou G; Yu Z; Song Y; Chen Y; Li Y
PLoS One; 2016; 11(12):e0167094. PubMed ID: 27907160
[TBL] [Abstract][Full Text] [Related]
14. Nucleolin Overexpression Confers Increased Sensitivity to the Anti-Nucleolin Aptamer, AS1411.
Sharma VR; Thomas SD; Miller DM; Rezzoug F
Cancer Invest; 2018; 36(9-10):475-491. PubMed ID: 30396283
[TBL] [Abstract][Full Text] [Related]
15. AS1411-conjugated gold nanoparticles affect cell proliferation through a mechanism that seems independent of nucleolin.
Kabirian-Dehkordi S; Chalabi-Dchar M; Mertani HC; Le Guellec D; Verrier B; Diaz JJ; Mehrgardi MA; Bouvet P
Nanomedicine; 2019 Oct; 21():102060. PubMed ID: 31336175
[TBL] [Abstract][Full Text] [Related]
16. Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells.
Noaparast Z; Hosseinimehr SJ; Piramoon M; Abedi SM
J Drug Target; 2015; 23(6):497-505. PubMed ID: 25673264
[TBL] [Abstract][Full Text] [Related]
17. AS1411 alters the localization of a complex containing protein arginine methyltransferase 5 and nucleolin.
Teng Y; Girvan AC; Casson LK; Pierce WM; Qian M; Thomas SD; Bates PJ
Cancer Res; 2007 Nov; 67(21):10491-500. PubMed ID: 17974993
[TBL] [Abstract][Full Text] [Related]
18. Old plants newly discovered: Cassia sieberiana D.C. and Cassia abbreviata Oliv. Oliv. root extracts inhibit in vitro HIV-1c replication in peripheral blood mononuclear cells (PBMCs) by different modes of action.
Leteane MM; Ngwenya BN; Muzila M; Namushe A; Mwinga J; Musonda R; Moyo S; Mengestu YB; Abegaz BM; Andrae-Marobela K
J Ethnopharmacol; 2012 May; 141(1):48-56. PubMed ID: 22326358
[TBL] [Abstract][Full Text] [Related]
19. Aptamer AS1411 utilized for super-resolution imaging of nucleolin.
Jing Y; Cai M; Zhou L; Jiang J; Gao J; Wang H
Talanta; 2020 Sep; 217():121037. PubMed ID: 32498876
[TBL] [Abstract][Full Text] [Related]
20. Biological studies of an ICG-tagged aptamer as drug delivery system for malignant melanoma.
Lopes-Nunes J; Lifante J; Shen Y; Ximendes EC; Jaque D; Iglesias-de la Cruz MC; Cruz C
Eur J Pharm Biopharm; 2020 Sep; 154():228-235. PubMed ID: 32707287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
